Search hospitals > South Carolina > Columbia
Prisma Health Richland Hospital
Claim this profileColumbia, South Carolina 29203
Global Leader in Tumors
Global Leader in Leukemia
Conducts research for Recurrence
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Lymphoma
196 reported clinical trials
13 medical researchers
Summary
Prisma Health Richland Hospital is a medical facility located in Columbia, South Carolina. This center is recognized for care of Tumors, Leukemia, Recurrence, Lymphoblastic Leukemia-Lymphoma, Lymphoma and other specialties. Prisma Health Richland Hospital is involved with conducting 196 clinical trials across 448 conditions. There are 13 research doctors associated with this hospital, such as Ki Chung, MD, Stuart L. Cramer, Jeffrey K. Giguere, and Souvik Sen.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Leukemia
Global LeaderStage II
FLT3 negative
Stage IV
Top PIs
Ki Chung, MDPrisma Health Cancer Institute - Eastside5 years of reported clinical research
Expert in Cancer
Expert in Tumors
95 reported clinical trials
196 drugs studied
Stuart L. CramerPrisma Health Richland Hospital4 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
55 reported clinical trials
107 drugs studied
Jeffrey K. GiguerePrisma Health Cancer Institute - Faris7 years of reported clinical research
Studies Cancer
Studies Breast Cancer
26 reported clinical trials
64 drugs studied
Souvik SenUniversity of South Carolina - Prisma3 years of reported clinical research
Studies Stroke
Studies Ischemia
3 reported clinical trials
5 drugs studied
Clinical Trials running at Prisma Health Richland Hospital
Brain Tumor
Germ Cell Tumors
Osteosarcoma
Acute Myeloid Leukemia
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Cancer
Astrocytoma
Tumors
Neuroblastoma
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Prisma Health Richland Hospital?
Prisma Health Richland Hospital is a medical facility located in Columbia, South Carolina. This center is recognized for care of Tumors, Leukemia, Recurrence, Lymphoblastic Leukemia-Lymphoma, Lymphoma and other specialties. Prisma Health Richland Hospital is involved with conducting 196 clinical trials across 448 conditions. There are 13 research doctors associated with this hospital, such as Ki Chung, MD, Stuart L. Cramer, Jeffrey K. Giguere, and Souvik Sen.